MiniMed Group MMED 深 沪
已收盘 10-30 16:00:00 美东时间
18.28
-0.970
-5.04%
华盛通- 最 高19.48
- 今 开19.48
- 成交量 813.40万股
- 最 低 18.035
- 昨 收 19.25
- 总市值 51.43亿
- 52周最高 24.43
- 市盈率 静 --
- 换手率 2.89%
- 52周最低 10.65
- 委 比 -17.52%
- 总股本 2.81亿
- 历史最高 24.43
- 量 比 1.14
- 振 幅 7.51%
- 历史最低 10.65
- 每 手 1
- 风险率 3.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MiniMed Group收涨1.74%，成交额9812.45万美元
10月27日，MiniMed Group（MMED）收涨1.74%，报18.66美元，成交额9812.45万美元，市值52.5亿美元。 行情数据 • 开盘价：...
10-27 05:06
MiniMed Group收跌2.83%，成交额3.78亿美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 05:07
Jim Cramer: This Health Care Stock Is A ‘Winner’, X-Energy Is ‘Losing Too Much Money’
On CNBC’s “Mad Money Lightning Round,” Jim Cramer said McKesson Corporation (NYSE:MCK) is a “winner” and it will go much higher. “It is exactly what you buy in this environment," he added. Supporting his view, Leerink Partners analyst Michael Cherny maintained an Outperform rating on McKesson on Oct...
10-15 19:58
Medtronic's MiniMed exchange offer oversubscribed; 18.3% acceptance
Medtronic (MDT) said on Monday that its exchange offer for MiniMed Group (MMED) shares was oversubscribed when it expired on October 9, 2026. The company will exchange 55.0M Medtronic shares for its r...
10-12 21:22
Medtronic PLC Stock (MDT) Moved Up by 3.36% on Oct 12: Key Drivers Unveiled
• Medtronic completed an oversubscribed exchange offer to divest its diabetes business. • New permanent CPT codes support long-term reimbursement and physician adoption. • Annual revenue reached $36.36B with an average analyst price target of $104.70.
10-12 16:15
美股大行评级 | 潜在涨幅179.23%！奥本海默上调Aurora Innovation目标价至16美元，维持"跑赢大市"评级
今日重点评级关注：奥本海默：维持Aurora Innovation"跑赢大市"评级，目标价从15美元升至16美元；富国银行：维持Applied Digital"超配"评级，目标价从50美元升至55美元
10-09 16:25
美股大行评级 | 潜在涨幅175.74%！美光科技获DA Davidson上调目标价至3000美元，维持"买入"评级
今日重点评级关注：DA Davidson：维持美光科技"买入"评级，目标价从2100美元升至3000美元；Leerink Partners：维持OmniAb"跑赢大市"评级，目标价从10美元升至12美元
10-08 12:30
Barclays Initiates Coverage On Minimed Group with Equal-Weight Rating, Announces Price Target of $22
Barclays analyst Christopher Pasquale initiates coverage on Minimed Group (NASDAQ:MMED) with a Equal-Weight rating and announces Price Target of $22.
10-07 21:02
MiniMed Study Links More Alert Responses To Better Diabetes Control
MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today presented new clinical evidence showing that people with type 1 diabetes using the MiniMed Smart MDI system who responded to more missed-dose and high-glucose alerts had, on average, 8.1 percentage points more Time in Range (TIR) a...
10-05 19:11
MiniMed appoints Sheila Denton as General Counsel & Corporate Secretary
NORTHRIDGE, Calif., Sept. 28, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that Sheila Denton has been named General Counsel & Corpora...
09-28 21:03
